 | • レポートコード：MRC2Q12-19168 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、腎臓損傷分子1（KIM-1）ELISAキットの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に腎臓損傷分子1（KIM-1）ELISAキットのグローバル市場のxxx％を占める「人間」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 腎臓損傷分子1（KIM-1）ELISAキットの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの腎臓損傷分子1（KIM-1）ELISAキット市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 腎臓損傷分子1（KIM-1）ELISAキットのグローバル主要プレイヤーには、Elabscience Biotechnology Inc.、Crystal Chem、Wuhan Fine Biotech Co., Ltd.、MyBiosource, Inc.、Shanghai Korain Biotech Co., Ltd.、Abcam、Enzo Life Sciences, Inc.、CUSABIO、CLOUD-CLONE CORP.、Creative Diagnostics、Bio-Techne、Innovative Research、RayBiotech, Inc.、Assay Genie、Cepham Life Sciences, Inc、Abbexa、Geno Technology, Inc.、ZodelBiotec Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 腎臓損傷分子1（KIM-1）ELISAキット市場は、種類と用途によって区分されます。世界の腎臓損傷分子1（KIM-1）ELISAキット市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 人間、マウス、ラット、豚、その他 【用途別セグメント】 病院、研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 腎臓損傷分子1（KIM-1）ELISAキット製品概要 - 種類別市場（人間、マウス、ラット、豚、その他） - 用途別市場（病院、研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の腎臓損傷分子1（KIM-1）ELISAキット販売量予測2017-2028 - 世界の腎臓損傷分子1（KIM-1）ELISAキット売上予測2017-2028 - 腎臓損傷分子1（KIM-1）ELISAキットの地域別販売量 - 腎臓損傷分子1（KIM-1）ELISAキットの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別腎臓損傷分子1（KIM-1）ELISAキット販売量 - 主要メーカー別腎臓損傷分子1（KIM-1）ELISAキット売上 - 主要メーカー別腎臓損傷分子1（KIM-1）ELISAキット価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（人間、マウス、ラット、豚、その他） - 腎臓損傷分子1（KIM-1）ELISAキットの種類別販売量 - 腎臓損傷分子1（KIM-1）ELISAキットの種類別売上 - 腎臓損傷分子1（KIM-1）ELISAキットの種類別価格 ・用途別市場規模（病院、研究機関、その他） - 腎臓損傷分子1（KIM-1）ELISAキットの用途別販売量 - 腎臓損傷分子1（KIM-1）ELISAキットの用途別売上 - 腎臓損傷分子1（KIM-1）ELISAキットの用途別価格 ・北米市場 - 北米の腎臓損傷分子1（KIM-1）ELISAキット市場規模（種類別、用途別） - 主要国別の腎臓損傷分子1（KIM-1）ELISAキット市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの腎臓損傷分子1（KIM-1）ELISAキット市場規模（種類別、用途別） - 主要国別の腎臓損傷分子1（KIM-1）ELISAキット市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の腎臓損傷分子1（KIM-1）ELISAキット市場規模（種類別、用途別） - 主要国別の腎臓損傷分子1（KIM-1）ELISAキット市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の腎臓損傷分子1（KIM-1）ELISAキット市場規模（種類別、用途別） - 主要国別の腎臓損傷分子1（KIM-1）ELISAキット市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの腎臓損傷分子1（KIM-1）ELISAキット市場規模（種類別、用途別） - 主要国別の腎臓損傷分子1（KIM-1）ELISAキット市場規模（トルコ、サウジアラビア） ・企業情報 Elabscience Biotechnology Inc.、Crystal Chem、Wuhan Fine Biotech Co., Ltd.、MyBiosource, Inc.、Shanghai Korain Biotech Co., Ltd.、Abcam、Enzo Life Sciences, Inc.、CUSABIO、CLOUD-CLONE CORP.、Creative Diagnostics、Bio-Techne、Innovative Research、RayBiotech, Inc.、Assay Genie、Cepham Life Sciences, Inc、Abbexa、Geno Technology, Inc.、ZodelBiotec Ltd. ・産業チェーン及び販売チャネル分析 - 腎臓損傷分子1（KIM-1）ELISAキットの産業チェーン分析 - 腎臓損傷分子1（KIM-1）ELISAキットの原材料 - 腎臓損傷分子1（KIM-1）ELISAキットの生産プロセス - 腎臓損傷分子1（KIM-1）ELISAキットの販売及びマーケティング - 腎臓損傷分子1（KIM-1）ELISAキットの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 腎臓損傷分子1（KIM-1）ELISAキットの産業動向 - 腎臓損傷分子1（KIM-1）ELISAキットのマーケットドライバー - 腎臓損傷分子1（KIM-1）ELISAキットの課題 - 腎臓損傷分子1（KIM-1）ELISAキットの阻害要因 ・主な調査結果 |
The Kidney Injury Molecule 1 (KIM-1) ELISA Kit quantifies KIM-1 concentrations in serum, plasma, and other biological fluids.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Kidney Injury Molecule 1 (KIM-1) ELISA Kit is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Kidney Injury Molecule 1 (KIM-1) ELISA Kit is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Kidney Injury Molecule 1 (KIM-1) ELISA Kit is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit include Elabscience Biotechnology Inc., Crystal Chem, Wuhan Fine Biotech Co., Ltd., MyBiosource, Inc., Shanghai Korain Biotech Co., Ltd., Abcam, Enzo Life Sciences, Inc., CUSABIO and CLOUD-CLONE CORP., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Kidney Injury Molecule 1 (KIM-1) ELISA Kit manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Kidney Injury Molecule 1 (KIM-1) ELISA Kit market. Further, it explains the major drivers and regional dynamics of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Elabscience Biotechnology Inc.
Crystal Chem
Wuhan Fine Biotech Co., Ltd.
MyBiosource, Inc.
Shanghai Korain Biotech Co., Ltd.
Abcam
Enzo Life Sciences, Inc.
CUSABIO
CLOUD-CLONE CORP.
Creative Diagnostics
Bio-Techne
Innovative Research
RayBiotech, Inc.
Assay Genie
Cepham Life Sciences, Inc
Abbexa
Geno Technology, Inc.
ZodelBiotec Ltd.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Kidney Injury Molecule 1 (KIM-1) ELISA Kit Segment by Type
Human
Mouse
Rat
Porcine
Other
Kidney Injury Molecule 1 (KIM-1) ELISA Kit Segment by Application
Hospital
Research Institute
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Kidney Injury Molecule 1 (KIM-1) ELISA Kit market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Kidney Injury Molecule 1 (KIM-1) ELISA Kit, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Kidney Injury Molecule 1 (KIM-1) ELISA Kit, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Kidney Injury Molecule 1 (KIM-1) ELISA Kit sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Kidney Injury Molecule 1 (KIM-1) ELISA Kit sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Elabscience Biotechnology Inc., Crystal Chem, Wuhan Fine Biotech Co., Ltd., MyBiosource, Inc., Shanghai Korain Biotech Co., Ltd., Abcam, Enzo Life Sciences, Inc., CUSABIO and CLOUD-CLONE CORP., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Kidney Injury Molecule 1 (KIM-1) ELISA Kit manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney Injury Molecule 1 (KIM-1) ELISA Kit sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Introduction
1.2 Market by Type
1.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Human
1.2.3 Mouse
1.2.4 Rat
1.2.5 Porcine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Estimates and Forecasts 2017-2028
2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Estimates and Forecasts 2017-2028
2.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region
2.4.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2017-2022)
2.4.2 Global Sales Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Region (2023-2028)
2.5 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region
2.5.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2017-2022)
2.5.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Manufacturers
3.1.1 Global Top Kidney Injury Molecule 1 (KIM-1) ELISA Kit Manufacturers by Sales (2017-2022)
3.1.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in 2021
3.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Manufacturers
3.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Manufacturers (2017-2022)
3.2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue in 2021
3.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type
4.1.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Historical Sales by Type (2017-2022)
4.1.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Forecasted Sales by Type (2023-2028)
4.1.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2017-2028)
4.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type
4.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Historical Revenue by Type (2017-2022)
4.2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Forecasted Revenue by Type (2023-2028)
4.2.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2017-2028)
4.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Type
4.3.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Type (2017-2022)
4.3.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application
5.1.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Historical Sales by Application (2017-2022)
5.1.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Forecasted Sales by Application (2023-2028)
5.1.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2017-2028)
5.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application
5.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Historical Revenue by Application (2017-2022)
5.2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Forecasted Revenue by Application (2023-2028)
5.2.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2017-2028)
5.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Application
5.3.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Application (2017-2022)
5.3.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price Forecast by Application (2023-2028)
6 North America
6.1 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Type
6.1.1 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2028)
6.1.2 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2028)
6.2 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Application
6.2.1 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2028)
6.2.2 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2028)
6.3 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country
6.3.1 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2028)
6.3.2 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Type
7.1.1 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2028)
7.1.2 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2028)
7.2 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Application
7.2.1 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2028)
7.2.2 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2028)
7.3 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country
7.3.1 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2028)
7.3.2 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Type
8.1.1 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2028)
8.1.2 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2028)
8.2 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Application
8.2.1 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2028)
8.2.2 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2028)
8.3 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Region
8.3.1 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2017-2028)
8.3.2 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Type
9.1.1 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2028)
9.1.2 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2028)
9.2 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Application
9.2.1 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2028)
9.2.2 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2028)
9.3 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country
9.3.1 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2028)
9.3.2 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Type
10.1.1 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2028)
10.1.2 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2028)
10.2 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Application
10.2.1 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2028)
10.2.2 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2028)
10.3 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country
10.3.1 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2028)
10.3.2 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Elabscience Biotechnology Inc.
11.1.1 Elabscience Biotechnology Inc. Corporation Information
11.1.2 Elabscience Biotechnology Inc. Overview
11.1.3 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Elabscience Biotechnology Inc. Recent Developments
11.2 Crystal Chem
11.2.1 Crystal Chem Corporation Information
11.2.2 Crystal Chem Overview
11.2.3 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Crystal Chem Recent Developments
11.3 Wuhan Fine Biotech Co., Ltd.
11.3.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
11.3.2 Wuhan Fine Biotech Co., Ltd. Overview
11.3.3 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
11.4 MyBiosource, Inc.
11.4.1 MyBiosource, Inc. Corporation Information
11.4.2 MyBiosource, Inc. Overview
11.4.3 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MyBiosource, Inc. Recent Developments
11.5 Shanghai Korain Biotech Co., Ltd.
11.5.1 Shanghai Korain Biotech Co., Ltd. Corporation Information
11.5.2 Shanghai Korain Biotech Co., Ltd. Overview
11.5.3 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shanghai Korain Biotech Co., Ltd. Recent Developments
11.6 Abcam
11.6.1 Abcam Corporation Information
11.6.2 Abcam Overview
11.6.3 Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Abcam Recent Developments
11.7 Enzo Life Sciences, Inc.
11.7.1 Enzo Life Sciences, Inc. Corporation Information
11.7.2 Enzo Life Sciences, Inc. Overview
11.7.3 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Enzo Life Sciences, Inc. Recent Developments
11.8 CUSABIO
11.8.1 CUSABIO Corporation Information
11.8.2 CUSABIO Overview
11.8.3 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CUSABIO Recent Developments
11.9 CLOUD-CLONE CORP.
11.9.1 CLOUD-CLONE CORP. Corporation Information
11.9.2 CLOUD-CLONE CORP. Overview
11.9.3 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CLOUD-CLONE CORP. Recent Developments
11.10 Creative Diagnostics
11.10.1 Creative Diagnostics Corporation Information
11.10.2 Creative Diagnostics Overview
11.10.3 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Creative Diagnostics Recent Developments
11.11 Bio-Techne
11.11.1 Bio-Techne Corporation Information
11.11.2 Bio-Techne Overview
11.11.3 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bio-Techne Recent Developments
11.12 Innovative Research
11.12.1 Innovative Research Corporation Information
11.12.2 Innovative Research Overview
11.12.3 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Innovative Research Recent Developments
11.13 RayBiotech, Inc.
11.13.1 RayBiotech, Inc. Corporation Information
11.13.2 RayBiotech, Inc. Overview
11.13.3 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 RayBiotech, Inc. Recent Developments
11.14 Assay Genie
11.14.1 Assay Genie Corporation Information
11.14.2 Assay Genie Overview
11.14.3 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Assay Genie Recent Developments
11.15 Cepham Life Sciences, Inc
11.15.1 Cepham Life Sciences, Inc Corporation Information
11.15.2 Cepham Life Sciences, Inc Overview
11.15.3 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Cepham Life Sciences, Inc Recent Developments
11.16 Abbexa
11.16.1 Abbexa Corporation Information
11.16.2 Abbexa Overview
11.16.3 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Abbexa Recent Developments
11.17 Geno Technology, Inc.
11.17.1 Geno Technology, Inc. Corporation Information
11.17.2 Geno Technology, Inc. Overview
11.17.3 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Geno Technology, Inc. Recent Developments
11.18 ZodelBiotec Ltd.
11.18.1 ZodelBiotec Ltd. Corporation Information
11.18.2 ZodelBiotec Ltd. Overview
11.18.3 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ZodelBiotec Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Chain Analysis
12.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Mode & Process
12.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales and Marketing
12.4.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Channels
12.4.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Distributors
12.5 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Trends
13.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
13.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Challenges
13.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Restraints
14 Key Findings in The Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Human
Table 3. Major Manufacturers of Mouse
Table 4. Major Manufacturers of Rat
Table 5. Major Manufacturers of Porcine
Table 6. Major Manufacturers of Other
Table 7. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2017-2022) & (K Units)
Table 10. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Region (2017-2022)
Table 11. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2023-2028) & (K Units)
Table 12. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Region (2023-2028)
Table 13. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Region (2017-2022)
Table 15. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Region (2023-2028)
Table 17. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Manufacturers (2017-2022)
Table 19. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Manufacturers (2017-2022)
Table 21. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Injury Molecule 1 (KIM-1) ELISA Kit as of 2021)
Table 24. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Offered
Table 26. Date of Manufacturers Enter into Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 29. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2023-2028) & (K Units)
Table 30. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Type (2017-2022)
Table 31. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Type (2023-2028)
Table 32. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Type (2017-2022)
Table 35. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Type (2023-2028)
Table 36. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 39. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2023-2028) & (K Units)
Table 40. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Application (2017-2022)
Table 41. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Application (2023-2028)
Table 42. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Application (2017-2022)
Table 45. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Application (2023-2028)
Table 46. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 49. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2023-2028) & (K Units)
Table 50. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 53. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2023-2028) & (K Units)
Table 54. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2022) & (K Units)
Table 57. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2023-2028) & (K Units)
Table 58. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 61. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2023-2028) & (K Units)
Table 62. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 65. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2023-2028) & (K Units)
Table 66. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2022) & (K Units)
Table 69. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2023-2028) & (K Units)
Table 70. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2023-2028) & (US$ Million)
Table 108. Elabscience Biotechnology Inc. Corporation Information
Table 109. Elabscience Biotechnology Inc. Description and Major Businesses
Table 110. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Elabscience Biotechnology Inc. Recent Developments
Table 113. Crystal Chem Corporation Information
Table 114. Crystal Chem Description and Major Businesses
Table 115. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Crystal Chem Recent Developments
Table 118. Wuhan Fine Biotech Co., Ltd. Corporation Information
Table 119. Wuhan Fine Biotech Co., Ltd. Description and Major Businesses
Table 120. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Wuhan Fine Biotech Co., Ltd. Recent Developments
Table 123. MyBiosource, Inc. Corporation Information
Table 124. MyBiosource, Inc. Description and Major Businesses
Table 125. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. MyBiosource, Inc. Recent Developments
Table 128. Shanghai Korain Biotech Co., Ltd. Corporation Information
Table 129. Shanghai Korain Biotech Co., Ltd. Description and Major Businesses
Table 130. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Shanghai Korain Biotech Co., Ltd. Recent Developments
Table 133. Abcam Corporation Information
Table 134. Abcam Description and Major Businesses
Table 135. Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Abcam Recent Developments
Table 138. Enzo Life Sciences, Inc. Corporation Information
Table 139. Enzo Life Sciences, Inc. Description and Major Businesses
Table 140. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Enzo Life Sciences, Inc. Recent Developments
Table 143. CUSABIO Corporation Information
Table 144. CUSABIO Description and Major Businesses
Table 145. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. CUSABIO Recent Developments
Table 148. CLOUD-CLONE CORP. Corporation Information
Table 149. CLOUD-CLONE CORP. Description and Major Businesses
Table 150. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. CLOUD-CLONE CORP. Recent Developments
Table 153. Creative Diagnostics Corporation Information
Table 154. Creative Diagnostics Description and Major Businesses
Table 155. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Creative Diagnostics Recent Developments
Table 158. Bio-Techne Corporation Information
Table 159. Bio-Techne Description and Major Businesses
Table 160. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Bio-Techne Recent Developments
Table 163. Innovative Research Corporation Information
Table 164. Innovative Research Description and Major Businesses
Table 165. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 166. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Innovative Research Recent Developments
Table 168. RayBiotech, Inc. Corporation Information
Table 169. RayBiotech, Inc. Description and Major Businesses
Table 170. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 171. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. RayBiotech, Inc. Recent Developments
Table 173. Assay Genie Corporation Information
Table 174. Assay Genie Description and Major Businesses
Table 175. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 176. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Assay Genie Recent Developments
Table 178. Cepham Life Sciences, Inc Corporation Information
Table 179. Cepham Life Sciences, Inc Description and Major Businesses
Table 180. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 181. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Cepham Life Sciences, Inc Recent Developments
Table 183. Abbexa Corporation Information
Table 184. Abbexa Description and Major Businesses
Table 185. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 186. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Abbexa Recent Developments
Table 188. Geno Technology, Inc. Corporation Information
Table 189. Geno Technology, Inc. Description and Major Businesses
Table 190. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 191. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Geno Technology, Inc. Recent Developments
Table 193. ZodelBiotec Ltd. Corporation Information
Table 194. ZodelBiotec Ltd. Description and Major Businesses
Table 195. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 196. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. ZodelBiotec Ltd. Recent Developments
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Distributors List
Table 201. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Customers List
Table 202. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Trends
Table 203. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
Table 204. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Challenges
Table 205. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Picture
Figure 2. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Type in 2021 & 2028
Figure 3. Human Product Picture
Figure 4. Mouse Product Picture
Figure 5. Rat Product Picture
Figure 6. Porcine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Research Institute
Figure 11. Other
Figure 12. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Report Years Considered
Figure 13. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales 2017-2028 (K Units)
Figure 14. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue 2017-2028 (US$ Million)
Figure 16. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Region (2017-2022)
Figure 18. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Region (2023-2028)
Figure 19. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales YoY (2017-2028) & (K Units)
Figure 20. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit in the World: Market Share by Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue in 2021
Figure 31. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2017-2028)
Figure 33. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2017-2028)
Figure 34. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2017-2028)
Figure 35. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2017-2028)
Figure 36. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2017-2028)
Figure 37. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2017-2028)
Figure 38. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2017-2028)
Figure 39. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2017-2028)
Figure 40. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Country (2017-2028)
Figure 41. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Country (2017-2028)
Figure 42. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2017-2028)
Figure 45. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2017-2028)
Figure 46. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2017-2028)
Figure 47. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2017-2028)
Figure 48. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Country (2017-2028)
Figure 49. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Country (2017-2028)
Figure 50. Germany Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 51. France Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Region (2017-2028)
Figure 61. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 64. India Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2017-2028)
Figure 71. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2017-2028)
Figure 73. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Country (2017-2028)
Figure 75. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Country (2017-2028)
Figure 76. Mexico Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 79. Colombia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Country (2017-2028)
Figure 86. Turkey Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (2017-2028) & (US$ Million)
Figure 89. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Value Chain
Figure 90. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed